FUOM

Across TCGA pan-cancer cohorts, FUOM mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated FUOM data layer compared with 20 for mass-spec protein.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher FUOM mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated FUOM expression acts as an unfavorable survival marker, although some lineages such as CCRCC and LUAD show a favorable association.

CCRCC, PDAC, and LUAD are the cancer types where FUOM mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	IV	1.000	0.451	.016	11	view →
PDAC	DFS	Tertile	II,III,IV	0.429	0.670	.027	6	view →
LUAD	DFS	Tertile	II,III,IV	0.657	0.344	.036	6	view →
LSCC	OS	Quartile	II,III,IV	0.642	0.996	.018	3	view →
HNSC	DFS	Median	IV	1.000	0.910	.041	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

FUOM–CCRCC (OS)

Open the CCRCC breakdown →